Denali Therapeutics Inc.
DNLI
Revenue
0.00
0.000.00%
3 Months ChangeAssets
1.14B
▲89.23M▲8.45%
3 Months ChangeLiabilities
131.09M
▲1.67M▲1.29%
3 Months ChangeFree Cash Flow
-136.55M
▼-20.78M▼-17.95%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-26
Form 8-K
ID: 0001714899-26-000020
2026-01-06
Form 8-K
ID: 0001714899-26-000004
2025-12-10
Form 8-K
ID: 0001628280-25-056363
2025-12-04
Form 8-K
ID: 0001714899-25-000209
2025-12-04
Form 8-K
ID: 0001714899-25-000208
2025-11-06
Form 10-Q
ID: 0001714899-25-000193
2025-11-06
Form 8-K
ID: 0001714899-25-000192
2025-10-14
Form 8-K
ID: 0001714899-25-000180
2025-08-11
Form 10-Q
ID: 0001714899-25-000170
2025-08-11
Form 8-K
ID: 0001714899-25-000167